期刊文献+

我国无创产前检测技术应用与政府监管的定性分析 被引量:3

Qualitative Analysis of Implementation and Governmental Regulation of Non-Invasive Prenatal Testing in China
下载PDF
导出
摘要 目的:评估我国无创产前检查技术(NIPT)的实施与政府管理现状,为进一步规范NIPT的临床应用提供决策参考。方法:采用半结构化方式对关键知情人进行定性访谈,共计开展13场焦点小组讨论,访谈了22名政府管理者、92名医务工作人员、20名孕妇。结果:NIPT试点项目中,不同的试点医院对于该技术的实施程度不同。医院实施NIPT主要有以下两种模式:医院自主实施NIPT和医院与第三方检测机构合作开展NIPT,第三方检测机构通常为其他具备高通量基因测序等分子遗传技术能力的生物遗传公司或医疗机构。不同利益相关者对于NIPT技术有不同的诉求与观点。关于NIPT的政府监管,当前存在诸多挑战与不足,如缺乏有效合理的定价与报销决策,对直接面向客户的"B2C"商业模式监管困难等。结论:应明确NIPT在产前筛查与诊断服务系统中的定位与功能,规范NIPT服务模式与资质要求,提高服务质量;建立NIPT技术应用的定价与补偿等配套支持系统,满足孕妇需求;政府对于NIPT的监督管理应在"过度限制"与"全面放开"中平衡决策,使NIPT规范、有序地开展。 Objective: This study aims to examine some initial outcomes of the NIPT pilot project in China, with a view to providing information for policy-makers to guide decision-making regarding governmental regulation of NIPT in China, Methods: Thirteen focus groups (FGs) were conducted in total. 22 relevant government officials 92 health workers and 20 patients were inter- viewed. FGs were conducted with a semi-structured question guide and the interviews were transcribed and analyzed using narrative and thematic approaches. Results: Hospitals differed in the extent of their involvement in NIPT. Two different models were adopt- ed : hospitals conducting the entire process of NIPT by themselves and hospitals collecting blood samples and having them tested by a third party, mostly companies specializing in genetic testing or other hospitals. With regard to governmental regulation, the gov- ernment faces multiple challenges such as establishing a reasonable price structure for NIPT services, dealing with for-profit genetic testing companies' direct-to-clients service model with its considerable ethical, privacy-protection and quality ramifications. Con- clusion : It is suggested to clearly determine the position and function of NIPT in prenatal screening and diagnosis system, to stand- ardize the NIPT service model and qualification requirements for improving quality, and to establish supporting system of pricing, insurance coverage and market regulation. It is also necessary for government to achieve a balance between under-regulation and o- ver-regulation.
作者 明坚 许艳 李娜 庞伟明 陈英耀 Ming Jian et al(School of Public Health, Fudan University, Key Lab of Health Technology Assessment, Ministry of Health, Collaborative Innovation Center of Social Risk Governance in Health, Shanghai, 20003)
出处 《医学与社会》 2017年第6期1-4,共4页 Medicine and Society
基金 2015年国家卫生计生委卫生技术评估项目资助 美国中华医学基金会卫生技术评估合作项目资助,编号为13-153
关键词 无创产前检测技术 实施现状 政府管理 Non-Invasive Prenatal Testing (NIPT) Implementation Status Governmental Regulation
  • 相关文献

参考文献4

二级参考文献77

  • 1严晓玲,段涛.唐氏综合征产前检查中的伦理学问题[J].中国产前诊断杂志(电子版),2011,3(1):48-50. 被引量:3
  • 2Lo Y M,Tein M S,Lau T K,et al.Quantitative analysis of fetal DNA in maternal plasma and serum:implications for noninvasive prenatal diagnosis[J].Am J Hum Genet,1998,62(4):768-775.
  • 3Poon L L,Leung T N,Lau T K,et al.Differential DNA methylation between fetus and mother as a s trategy for detecting fetal DNA in maternal plasma[J].Clin Chem,2002,48(1):35-41.
  • 4Lun F M,Jin Y Y,Sun H,et al.Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA[J].Clin Chem,2011,57(6):917-919.
  • 5Chiu R W,Akolekar R,Zheng Y W,et al.Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing:large scale validity study[J].BMJ,2011,342:c7401.
  • 6Chiu R W K,Sun H,Akolekar R,et al.Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21[J].Clin Chem,2010,56(3):459-463.
  • 7Chen E Z,Chiu R W,Sun H,et al.Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing[J].PLoS One,2011,6(7):e21791.
  • 8Wright C F,Chitty L S.Cell-free fetal DNA and RNA in maternal blood:implications for safer antenatal testing[J].BMJ,2009,339:b2451.
  • 9中华人民共和国卫生部.中国出生缺陷防治报告(2012)[R].北京:中华人民共和国卫生部,2012,3.
  • 10Wald N J, Cuckle HS, Densem J, et al. Maternal serum screening for Down's syndrome in early pregnancy [J] . 1988, 297 (6653): 883-887.

共引文献79

同被引文献30

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部